IP Library › Granted Patent US 10,179,230
Granted Patent B2
US 10,179,230 · App. 15/881,616 · Granted Jan 15, 2019

Systems and methods for radiographically identifying an access port

Inventors: Kelly B. Powers (North Salt Lake, UT); William R. Barron (Riverton, UT)
Assignee: Bard Peripheral Vascular, Inc.
A61M39/0208A61B6/12A61M39/0247A61M2039/0205A61M2039/0211A61M2039/0238A61M2205/32A61M2205/582A61M2205/6054A61M2207/00Y10T156/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,179,230
App. No.
15/881,616
Granted
Jan 15, 2019
Kind
B2
Abstract

An access port for subcutaneous implantation is disclosed. Such an access port may comprise a body for capturing a septum for repeatedly inserting a needle therethrough into a cavity defined within the body. Further, the access port may include at least one feature structured and configured for identification of the access port subsequent to subcutaneous implantation. Methods of identifying a subcutaneously implanted access port are also disclosed. For example, a subcutaneously implanted access port may be provided and at least one feature of the subcutaneously implanted access port may be perceived. Further, the subcutaneously implanted access port may be identified in response to perceiving the at least one feature. In one embodiment, an identification feature is included on an insert that is incorporated into the access port so as to be visible after implantation via x-ray imaging technology.

Claims (24)

1. A power injectable access port, comprising:

a port base including a first fluid cavity;

a first radiopaque identification feature comprising a silk screen deposit having a thickness protruding from an outer surface of the port base such that it is perceivable by sight and touch prior to implantation of the power injectable access port, the first radiopaque identification feature observable via imaging technology subsequent to subcutaneous implantation of the power injectable access port, the first radiopaque identification feature indicating that the power injectable access port is suitable for power injection;

a port cap; and

a first septum captured between the port cap and the port base.

2. The power injectable access port according to claim 1 , further comprising a second fluid cavity and a second septum, wherein the first fluid cavity is covered by the first septum, and the second fluid cavity is covered by the second septum.

3. The power injectable access port according to claim 2 , further comprising a second radiopaque identification feature comprising a silk screen deposit having a thickness protruding from the outer surface of the port base.

4. The power injectable access port according to claim 3 , wherein the first radiopaque identification feature is positioned under the first fluid cavity, and wherein the second radiopaque identification feature is deposited on the outer surface of the port base under the second fluid cavity.

5. The power injectable access port according to claim 4 , wherein the first radiopaque identification feature includes an abbreviation for computed tomography.

6. The power injectable access port according to claim 5 , wherein the second radiopaque identification feature is selected from the group consisting of a pattern, a symbol, an indicia, one or more alphanumeric characters, and combinations thereof.

7. The power injectable access port according to claim 6 , wherein the abbreviation for computed tomography includes the letters “C” and “T”.

8. The power injectable access port according to claim 7 , wherein the second radiopaque identification feature is distinguishable from the first radiopaque identification feature.

9. The power injectable access port according to claim 3 , wherein the second radiopaque identification feature is distinguishable from the first radiopaque identification feature.

10. The power injectable access port according to claim 1 , wherein the first radiopaque identification feature is positioned under the first fluid cavity.

11. The power injectable access port according to claim 10 , wherein the first radiopaque identification feature includes an abbreviation for computed tomography.

12. The power injectable access port according to claim 11 , wherein the abbreviation for computed tomography includes the letters “C” and “T”.

13. The power injectable access port according to claim 1 , wherein the imaging technology includes x-ray imaging technology.

14. The power injectable access port according to claim 1 , wherein the first radiopaque identification feature includes an abbreviation for computed tomography.

15. The power injectable access port according to claim 14 , wherein the abbreviation for computed tomography includes the letters “C” and “T”.

16. The power injectable access port according to claim 1 , wherein the first radiopaque identification feature comprises a first material, and wherein the port base comprises a second material different from the first material.

17. The power injectable access port according to claim 16 , wherein the port base comprises a bio-compatible plastic material.

18. The power injectable access port according to claim 17 , wherein the first radiopaque identification feature comprises a radiopaque material and a silicone material.

19. The power injectable access port according to claim 18 , wherein the radiopaque material is selected from the group consisting of tungsten, barium, titanium, and combinations thereof.

20. The power injectable access port according to claim 1 , wherein the first radiopaque identification feature comprises a radiopaque material and a silicone material.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 21, 2018
From: BARRON, WILLIAM R.
To: BARD PERIPHERAL VASCULAR, INC.
Reel/Frame 047565/0993 →
Continuity (10)
Division 14599376 · Jan 16, 2015
Division 13776517 · Feb 25, 2013
Division 13250909 · Sep 30, 2011
Division 12796133 · Jun 8, 2010
Continuation In Part 12610084 · Oct 30, 2009
Continuation In Part 12420028 · Apr 7, 2009
Continuation In Part 11368954 · Mar 6, 2006
Provisional Application 61110507 · Oct 31, 2008
Provisional Application 60658518 · Mar 4, 2005
Related Publication 20180161565A1 · Jun 14, 2018
Cited By (3)
US 12,274,850 US 12,734,347 US 12,734,795